EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”

MedComm · 2026-06 · 7 (6)

DOI: 10.1002/mco2.70757 ↗

Kurz gefasst

Korrektur in der Zeitschrift MedComm, online erschienen am 29.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This corrects the article DOI: 10.1002/mco2.70715.].

Zitieren

APA

(2026). Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”. MedComm, 7(6). https://doi.org/10.1002/mco2.70757

Vancouver

Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”. MedComm. 2026;7(6). doi:10.1002/mco2.70757

BibTeX
@article{euvimed2026,
  title = {Correction to “Lycorine Derivative Inhibits SARS‐CoV‐2 Replication by Reducing −1 Programmed Ribosomal Frameshifting via Targeting ZAP”},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {6},
  doi = {10.1002/mco2.70757}
}
Kostenlos starten →